ALB vs NMRA · rev $1.74B vs $283.5M cap
Albemarle Corp (ALB) versus Neumora Therapeutics, Inc. (NMRA) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
NMRA does not have a complete income-statement cache yet.
ALB currently screens at market cap $8.00B. NMRA currently screens at market cap $283.5M.
Not investment advice. Open the ALB and NMRA stock pages for the full models.
Not investment advice.